Patents by Inventor John H. Connor

John H. Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9617325
    Abstract: The methods and compositions described herein are based, in part, on the discovery of a polypeptide of soluble CD23 (sCD23) that binds and sequesters IgE. Thus, the sCD23 peptides, polypeptides and derivatives described herein are useful for treating conditions or disorders involving increased IgE levels such as e.g., allergy, anaphylaxis, inflammation, lymphoma, and certain cancers.
    Type: Grant
    Filed: December 29, 2014
    Date of Patent: April 11, 2017
    Assignees: Boston Medical Center Corporation, Trustees of Boston University
    Inventors: Lisa Ganley-Leal, John H. Connor
  • Publication number: 20150183848
    Abstract: The methods and compositions described herein are based, in part, on the discovery of a polypeptide of soluble CD23 (sCD23) that binds and sequesters IgE. Thus, the sCD23 peptides, polypeptides and derivatives described herein are useful for treating conditions or disorders involving increased IgE levels such as e.g., allergy, anaphylaxis, inflammation, lymphoma, and certain cancers.
    Type: Application
    Filed: December 29, 2014
    Publication date: July 2, 2015
    Applicants: BOSTON MEDICAL CENTER CORPORATION, TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Lisa GANLEY-LEAL, John H. CONNOR
  • Patent number: 8945575
    Abstract: The methods and compositions described herein are based, in part, on the discovery of a polypeptide of soluble CD23 (sCD23) that binds and sequesters IgE. Thus, the sCD23 peptides, polypeptides and derivatives described herein are useful for treating conditions or disorders involving increased IgE levels such as e.g., allergy, anaphylaxis, inflammation, lymphoma, and certain cancers.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: February 3, 2015
    Assignees: Trustees of Boston University, Boston Medical Center Corporation
    Inventors: Lisa Ganley-Leal, John H. Connor
  • Publication number: 20130065777
    Abstract: A sensor scheme combining nano-photonics and nano-fluidics on a single platform through the use of free-standing photonic crystals is described. By harnessing nano-scale openings, both fluidics and light can be manipulated at sub-wavelength scales. The convective flow is actively steered through the nanohole openings for effective delivery of the analytes to the sensor surface, and refractive index changes are detected in aqueous solutions. Systems and methods using cross-polarization measurements to further improve the detection limit by increasing the signal-to-noise ratio are also described.
    Type: Application
    Filed: December 3, 2010
    Publication date: March 14, 2013
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Hatice Altug, Ahmet Ali Yanik, Min Huang, Alp Artar, John H. Connor
  • Publication number: 20130039934
    Abstract: The methods and compositions described herein are based, in part, on the discovery of a polypeptide of soluble CD23 (sCD23) that binds and sequesters IgE. Thus, the sCD23 peptides, polypeptides and derivatives described herein are useful for treating conditions or disorders involving increased IgE levels such as e.g., allergy, anaphylaxis, inflammation, lymphoma, and certain cancers.
    Type: Application
    Filed: December 1, 2010
    Publication date: February 14, 2013
    Applicants: Trustees of Boston University, Boston Medical center Corporation
    Inventors: Lisa Ganley-Leal, John H. Connor